Coherus BioSciences Inc. (CHRS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.60

-0.61%

After-hours Dec 13, 2024, 07:51 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	257.24M	211.04M	326.55M	475.82M	356.07M	1.56M	1.56M	190.11M	30.04M	31.11M	2.75M	1.90M
Cost of Revenue	162.78M	70.08M	57.59M	37.67M	17.08M	3.23M	160.53M	254.44M	212.68M	78.22M	31.28M	34.89M
Gross Profit	94.46M	140.96M	268.96M	438.16M	338.99M	-1.68M	-158.97M	-64.33M	-182.64M	-47.12M	-28.53M	-32.99M
Operating Income	-203.20M	-256.88M	-263.86M	156.32M	107.77M	-204.42M	-232.14M	-115.93M	-219.07M	-64.68M	-35.99M	-38.52M
Interest Income	-	30.57M	21.56M	20.57M	16.00M	-	-	-	-	-	-	-
Pretax Income	-238.27M	-291.75M	-287.10M	135.71M	92.78M	-209.41M	-238.29M	-127.79M	-223.94M	-87.18M	-53.63M	-33.02M
Net Income	-237.89M	-326.63M	-306.32M	132.24M	89.83M	-209.34M	-238.17M	-127.34M	-223.26M	-87.13M	-53.63M	-33.02M
Selling & General & Admin	185.62M	198.48M	169.71M	139.08M	137.04M	94.18M	71.30M	51.60M	36.05M	17.56M	7.46M	5.53M
Research & Development	109.44M	199.36M	363.11M	142.76M	94.19M	110.24M	162.39M	254.44M	213.06M	78.22M	31.28M	34.89M
Other Expenses	-	3.82M	-283.00K	554.00K	2.61M	4.69M	3.40M	-3.88M	-4.84M	-18.59M	-12.35M	7.01M
Operating Expenses	301.45M	397.84M	532.82M	281.84M	231.22M	204.42M	233.69M	306.04M	249.11M	95.79M	38.74M	40.42M
Interest Expense	40.54M	32.47M	22.96M	21.17M	17.60M	9.68M	9.55M	7.98M	33.00K	3.90M	5.29M	1.51M
Selling & Marketing Expenses	-	10.50M	8.70M	3.80M	4.50M	2.80M	-	-	-	-	-	-
Cost & Expenses	460.44M	467.92M	590.41M	319.50M	248.30M	204.42M	233.69M	306.04M	249.11M	95.79M	38.74M	40.42M
Income Tax	-380.00K	34.87M	19.22M	3.46M	2.94M	4.69M	9.44M	656.00K	-7.35M	-15.41M	-7.06M	8.53M
Shares Outstanding (Basic)	94.16M	77.63M	75.45M	71.41M	69.68M	65.01M	53.13M	41.91M	37.12M	8.19M	18.08M	18.08M
Shares Outstanding (Diluted)	94.16M	77.63M	75.45M	83.49M	73.19M	65.03M	53.13M	41.91M	37.12M	8.19M	18.08M	18.08M
EPS (Basic)	-2.53	-4.21	-4.06	1.85	1.29	-3.22	-4.48	-3.04	-6.01	-10.64	-2.97	-1.83
EPS (Diluted)	-2.53	-4.21	-4.06	1.62	1.23	-3.22	-4.48	-3.04	-6.01	-10.64	-2.97	-1.83
EBITDA	-193.94M	-255.58M	-260.69M	161.84M	111.03M	-204.42M	-225.34M	-116.81M	-222.04M	-82.72M	-47.94M	-31.28M
Depreciation & Amortization	3.79M	3.70M	5.66M	4.97M	3.26M	3.23M	3.40M	3.00M	1.87M	674.00K	404.00K	221.00K